Daniel Keesman, Martin Hollenhorst, Jurgen Dormann, Klaus Pohle, Richard Roy, Thure Etzold, Joseph Donahue

Daniel Keesman, co-CEO and chief operating officer, and Martin Hollenhorst, co-CEO and chief financial officer, as well as all three members of the supervisory board of Lion Bioscience — Jurgen Dormann, Klaus Pohle, and Richard Roy — have resigned. Thure Etzold, managing director for Lion Bioscience UK, and Joseph Donahue, chief business officer for Lion Bioscience in North America, have been appointed as co-CEOs. Etzold will be responsible for product development and services, and Donahue will assume responsibility for finance and administration. See story, p. 1, for further details.